ArkVax Seed
2 known investors
Find your way into ArkVax Seed
147 people in our graph share verified history with the ArkVax Seed team — schools, employers, funds. One of them is your warm intro.
Alix Tricotunlockedknows Jon Cuccui · together at Queen Mary University of London
×11knows the team · via Queen Mary University of London
ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.
Founders & leadership
JC
Jon CuccuiinFounderJon Cuccui is founder and CEO of ArkVax, which develops glycoconjugate vaccines for animal health. He previously served as an Associate Professor of Glycoengineering and Glycobiology at the London School of Hygiene and Tropical Medicine, where he conducted vaccine development research.
Investors · 2
Frequently asked questions
- What does ArkVax Seed do?
- ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.
- Who founded ArkVax Seed?
- ArkVax Seed was founded by Jon Cuccui.
- Who are ArkVax Seed's investors?
- ArkVax Seed's investors include Future Planet Capital, UK Innovation & Science Seed Fund.